C1orf59 peptides and vaccines including the same

Details for Australian Patent Application No. 2009332389 (hide)

Owner Oncotherapy Science, Inc.

Inventors Tsunoda, Takuya; Ohsawa, Ryuji; Yoshimura, Sachiko; Watanabe, Tomohisa

Agent Davies Collison Cave

Pub. Number AU-A-2009332389

PCT Pub. Number WO2010/073551

Priority 61/145,912 20.01.09 US; 2008-327358 24.12.08 JP

Filing date 17 December 2009

Wipo publication date 1 July 2010

International Classifications

C12N 15/00 (2006.01) Mutation or genetic engineering

A61K 39/00 (2006.01) Medicinal preparations containing antigens or antibodies

A61P 35/00 (2006.01) Antineoplastic agents

C07K 7/06 (2006.01) Peptides having 5 to 20 amino acids in a fully defined sequence

C07K 14/705 (2006.01) Peptides having more than 20 amino acids

Event Publications

14 July 2011 PCT application entered the National Phase

  PCT publication WO2010/073551 Priority application(s): WO2010/073551

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2009332390-Apparatus for protecting power supply circuit of three-phase inverter

2009332369-Muscle-building agent